Daisuke Shii

Title: Daisuke Shii: Innovator in Therapeutic Agents

Introduction

Daisuke Shii is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of meibomian gland dysfunction. With a total of 4 patents to his name, Shii continues to push the boundaries of innovation in his field.

Latest Patents

One of Shii's latest patents focuses on a therapeutic agent for meibomian dysfunction. This method involves suppressing the obstruction of the meibomian gland in a mammalian subject. The method comprises administering an eye drop containing 0.01 to 0.5% (w/v) of sirolimus or a pharmaceutically acceptable salt thereof as the sole active ingredient. The eye drop is to be administered to the eye of the mammalian subject 1 to 2 times per day. This innovative approach aims to improve the quality of life for individuals suffering from this condition.

Career Highlights

Daisuke Shii is currently associated with Santen Pharmaceutical Co., Ltd., where he applies his expertise in developing therapeutic solutions. His work has garnered attention in the pharmaceutical industry, showcasing his commitment to advancing medical treatments.

Collaborations

Shii collaborates with talented professionals in his field, including Tomoko Oda and Kenji Kawashima. These collaborations enhance the innovative processes within his projects and contribute to the overall success of their endeavors.

Conclusion

Daisuke Shii stands out as a dedicated inventor in the realm of therapeutic agents. His innovative methods and collaborative spirit continue to drive advancements in the treatment of meibomian gland dysfunction.